Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

about

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

Item

http://www.wikidata.org/entity/Q47210528

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

@en

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

@nl

type

Item

label

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

@en

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

@nl

prefLabel

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

@en

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.

@nl

P1476

Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer

@en

P2093

Fikrettin Şahin

http://www.w3.org/2001/XMLSchema#string

Merve Kongur

http://www.w3.org/2001/XMLSchema#string

Selami Demirci

http://www.w3.org/2001/XMLSchema#string

Serli Canikyan

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced clear-cell renal-cell carcinoma

Cancer statistics, 2016

Novel immunotherapy in metastatic renal cell carcinoma.

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

Novel treatment strategies in clear-cell metastatic renal cell carcinoma.

Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells.

Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro.

Schiff Base-Poloxamer P85 Combination Prevents Prostate Cancer Progression in C57/Bl6 Mice.

Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.

Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.

P304

247-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-017-1782-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dilek Telci

Bülent Dede

Ayşegül Doğan

P577

2017-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29288416

http://www.w3.org/2001/XMLSchema#string